Argonne National Laboratory

Life Sciences
Having a healthy impact on energy, medicine and the environment

Argonne National Laboratory's life sciences research has yielded a portfolio of advanced technologies that are having a profound impact on medical technologies and therapies, energy production and sustainability, and bioremediation.

Argonne's roster of world-class biology and environmental scientists develop viable technologies — from cancer therapies and antibody engineering to biological methane production and engineered biofuels — that are based on a solid foundation of basic research.

Argonne works with existing and start-up businesses to license our patented life sciences technologies and to develop, analyze, and test bio-based new and emerging technologies.

View Licensable Life Sciences Technologies »

Medical Therapies

Endoscopic Electron-Beam Cancer Therapy

  • Cost-effective
  • Can treat cancer in inoperable or radiation-sensitive areas

Therapeutic Hypothermia: Protective Cooling Using Medical Ice Slurry

  • Portable, automatic
  • Advantageous for emergency care, cooling during surgeries, organ harvesting

Three-Dimensional Thermal Tomography Advances Cancer Treatment

  • Lowers medical costs due to lessened side effects
  • Noninvasive, enhances healing and detects other conditions

Medical Technologies

Metal Oxide Semiconductor Nanoparticles Open the Door to New Medical Innovations

  • Potential commercial applications
  • Targeting ability allows use in disease treatment, in vivo gene surgery, and cellular drug delivery

Molecule Nanoweaver Creates High-Tech Medical Patches and Multilayered Capsules

  • May increase the market for medical patches
  • Allows creation of medical patches that are more efficient at delivering medication and treatment, speeding up the healing process

Synthesizing Pharmaceuticals Using Containerless Processing

  • Offers higher yields than current state-of-the-art methods
  • Provides a more effective means of synthesizing amorphous pharmaceutical compounds

Protein and Antibody Technologies

Biomimetic Materials for Protein Storage and Transport

  • Enables delivery to sites outside of initial extraction and storage facilities
  • Allows isolation, maintenance, and indefinite storage of protein in its native state

Rhodobacter System for the Expression of Membrane Proteins

  • Lower production costs
  • Yields a higher fraction of proteins in soluble form

Systematic Method to Improve Antibody Stability

  • Fast and inexpensive method
  • Can be used to generate multiple products from the same antibody by fine-tuning stability levels

Synthesizing Membrane Proteins Using In Vitro Methodology

  • A cell-free, in vitro protein synthesis method for targeting difficult-to-study proteins
  • Quicker and easier than conventional methodologies, this system does not require host cells

Biotechnologies

Magneto-Optic Biosensor Using Bio-Functionalized Magnetic Nanoparticles

  • More cost-effective than existing technologies
  • Enables more rapid and sensitive detection

Biofuels

Engineering Biofuels from Photosynthetic Bacteria

  • 30 to 70 percent of the fuel’s waste can be used to create other fuel sources
  • Combines both engineered and natural photosynthetic mechanisms to generate the fuel

Natural Gas Quality Biogas

  • Transportation Fuel and Organic Solid Fertilizer from Anaerobic Digestion of Wastewater Solids and Other Organic Wastes
  • Organic solid fertilizer is rich in nitrogen, phosphorous, potassium, and Sulfur

Other

Discrimination of Bacillus anthracis from Closely Related Microorganisms by Analysis of 16S and 23SrRNA with Oligonucleotide Microchip

Enhanced Renewable Methane Production System

  • Low cost
  • Delivers near-pipeline-quality gas and eliminates carbon dioxide emissions

Color X-ray histology for multi-stained biologic sample, IN-14-073

  • A system for staining tissue and X-ray imaging using multiple illumination energies
  • Allows for differentiation between 3D imaging of features at the micron scale
  • Provides technique for morphologically phenotyping opaque organisms

Contact us

To learn about the many ways you can collaborate with Argonne, contact partners@anl.gov or 800-627-2596.